EGFR antibody (Extracellular Domain) (FITC)
Quick Overview for EGFR antibody (Extracellular Domain) (FITC) (ABIN2473408)
Target
See all EGFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Characteristics
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
Immunogen
- Extracellular domain of human EGF-receptor from head and neck carcinoma
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.1 mg/mL
-
-
-
: "The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (review)." in: International journal of oncology, Vol. 4, Issue 2, pp. 277-96, (2011) (PubMed).
: "Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin." in: Cancer research, Vol. 70, Issue 5, pp. 2030-40, (2010) (PubMed).
-
: "The receptor for EGF and its ligands - expression, prognostic value and target for therapy in cancer (review)." in: International journal of oncology, Vol. 4, Issue 2, pp. 277-96, (2011) (PubMed).
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Alternative Name
- EGF R
-
Background
- Synonyms: EPIDERMAL GROWTH FACTOR RECEPTOR
-
Gene ID
- 1956
-
UniProt
- P00533
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Target
-